News
-
VPH commends EMA's Mechanistic Modelling Guideline Initiative urging broader scope
On 30 May 2025, VPH presented its formal comments and suggestions on the European Medicines Agency's (EMA) proposed guideline for assessing and reporting mechanistic models in the context of model informed drug development (EMA 2025).
-Read more-
-
New funding opportunities for the in silico medicine community
The European Commission has announced the Health and Research Infrastructures 2025 Work Programmes and these programmes contain several opportunities in the in silico medicine domain.
-Read more-
-
News from the 8th VPH Summer School this week in Barcelona
The Summer School provides junior engineers, early researchers and medical doctors with an integrative view of state-of-the-art research for in silico medicine, following a complete pipeline from basic science and clinical needs, to model application.
-Read more-
-
VPH engages with regulatory and policy stakeholders at the annual RAPS Euro Convergence conference
Held from 13 to 16 May 2025 in Brussels, the RAPS Euro Convergence conference is the Europe's premier regulatory affairs event for healthcare products.
-Read more-
-
Parliamentary question on use of non-human primates in experiments and phasing out animal testing
On 30 April 2025, MEP Niels Fuglsang submitted a parliamentary question (E-001722/2025) to the European Commission concerning the use of non-human primates in animal testing.
-Read more-
-
Workshop on (dis)trust in data-driven medicine
On 14 May 2025 a workshop on (dis)trust in data-driven medicine took place in Leuven (Belgium), as an interdisciplinary effort between different institutes within KU Leuven; iSiHealth Institute, the Meaningful Interactions Lab (Mintlab), the Digital Society Institute (DigiSoc) and Life Sciences & Society Lab.
-Read more-
